[go: up one dir, main page]

SI2709633T1 - Metoda zdravljenja ali profilaksa bakterijske vaginoze - Google Patents

Metoda zdravljenja ali profilaksa bakterijske vaginoze

Info

Publication number
SI2709633T1
SI2709633T1 SI201131809T SI201131809T SI2709633T1 SI 2709633 T1 SI2709633 T1 SI 2709633T1 SI 201131809 T SI201131809 T SI 201131809T SI 201131809 T SI201131809 T SI 201131809T SI 2709633 T1 SI2709633 T1 SI 2709633T1
Authority
SI
Slovenia
Prior art keywords
prophylaxis
treatment
bacterial vaginosis
vaginosis
bacterial
Prior art date
Application number
SI201131809T
Other languages
English (en)
Inventor
Jeremy Robert Arthur Paull
Jacinth Kincaid Fairley
Clare Frances Price
Gareth Rhys Lewis
Original Assignee
Starpharma Pty Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Starpharma Pty Ltd filed Critical Starpharma Pty Ltd
Publication of SI2709633T1 publication Critical patent/SI2709633T1/sl

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/74Synthetic polymeric materials
    • A61K31/795Polymers containing sulfur
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/74Synthetic polymeric materials
    • A61K31/785Polymers containing nitrogen
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/02Peptides of undefined number of amino acids; Derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0034Urogenital system, e.g. vagina, uterus, cervix, penis, scrotum, urethra, bladder; Personal lubricants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/06Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • A61P15/02Drugs for genital or sexual disorders; Contraceptives for disorders of the vagina
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • A61P15/08Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10Antimycotics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • A61P31/14Antivirals for RNA viruses
    • A61P31/18Antivirals for RNA viruses for HIV
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • A61P31/20Antivirals for DNA viruses
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • A61P31/20Antivirals for DNA viruses
    • A61P31/22Antivirals for DNA viruses for herpes viruses
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00Antiparasitic agents
    • A61P33/02Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2121/00Preparations for use in therapy
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02ATECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Reproductive Health (AREA)
  • Virology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Gynecology & Obstetrics (AREA)
  • Endocrinology (AREA)
  • Urology & Nephrology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biotechnology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Pregnancy & Childbirth (AREA)
  • AIDS & HIV (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
SI201131809T 2011-05-16 2011-07-14 Metoda zdravljenja ali profilaksa bakterijske vaginoze SI2709633T1 (sl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201161486700P 2011-05-16 2011-05-16
PCT/AU2011/000891 WO2012155172A1 (en) 2011-05-16 2011-07-14 Method of treatment or prophylaxis of bacterial vaginosis
EP11865925.9A EP2709633B1 (en) 2011-05-16 2011-07-14 Method of treatment or prophylaxis of bacterial vaginosis

Publications (1)

Publication Number Publication Date
SI2709633T1 true SI2709633T1 (sl) 2020-01-31

Family

ID=47176018

Family Applications (1)

Application Number Title Priority Date Filing Date
SI201131809T SI2709633T1 (sl) 2011-05-16 2011-07-14 Metoda zdravljenja ali profilaksa bakterijske vaginoze

Country Status (24)

Country Link
US (1) US9155760B2 (sl)
EP (1) EP2709633B1 (sl)
JP (2) JP6057987B2 (sl)
KR (2) KR102096114B1 (sl)
CN (2) CN107669698A (sl)
AU (1) AU2011368322B2 (sl)
BR (1) BR112013029661B1 (sl)
CA (1) CA2836168C (sl)
CY (1) CY1122258T1 (sl)
DK (1) DK2709633T3 (sl)
ES (1) ES2753531T3 (sl)
HK (1) HK1247572A1 (sl)
HR (1) HRP20191888T1 (sl)
HU (1) HUE047170T2 (sl)
IL (1) IL229439A (sl)
LT (1) LT2709633T (sl)
MX (1) MX361009B (sl)
PL (1) PL2709633T3 (sl)
PT (1) PT2709633T (sl)
RS (1) RS59598B1 (sl)
RU (1) RU2632110C2 (sl)
SI (1) SI2709633T1 (sl)
SM (1) SMT201900610T1 (sl)
WO (1) WO2012155172A1 (sl)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2014043576A1 (en) 2012-09-13 2014-03-20 Starpharma Pty Limited Method of treatment or prophylaxis of infections of the eye
JP6487534B2 (ja) 2014-09-05 2019-03-20 シンビオミックス セラピューティクス、エルエルシー 細菌性膣炎の治療に使用するためのセクニダゾール
CA2988082C (en) 2015-06-01 2020-09-29 Symbiomix Therapeutics, Llc Novel nitroimidazole formulations and uses thereof
SG11202112332VA (en) * 2020-04-15 2021-12-30 Starpharma Pty Ltd Method of prophylaxis of coronavirus and/or respiratory syncytial virus infection
US12280037B2 (en) 2020-09-22 2025-04-22 Evofem Biosciences, Inc. Method and pharmaceutical composition for treating or preventing trichomoniasis and uses thereof
KR20250028829A (ko) 2023-08-22 2025-03-04 우석대학교 산학협력단 페닐아세트산을 포함하는 세균성 질염의 예방 또는 치료용 조성물
CN119235837B (zh) * 2024-12-02 2025-03-25 温州医科大学附属第一医院 一种专用于抗浅部真菌细菌感染的组合物及其制备方法

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AUPM623994A0 (en) * 1994-06-15 1994-07-07 Biomolecular Research Institute Limited Antiviral dendrimers
AUPO104496A0 (en) * 1996-07-17 1996-08-08 Biomolecular Research Institute Limited Angiogenic inhibitory compounds
AUPP584298A0 (en) * 1998-09-14 1998-10-08 Starpharma Limited Antimicrobial and antiparasitic agents
US7572459B2 (en) * 1998-09-14 2009-08-11 Starpharma Pty Ltd. Anionic or cationic dendrimer antimicrobial or antiparasitic compositions
AUPR412801A0 (en) * 2001-03-30 2001-05-03 Starpharma Limited Agent for the prevention and treatment of sexually transmitted disease s - I
ES2562055T3 (es) * 2005-10-18 2016-03-02 Starpharma Pty Limited Sistema de administración de una composición dendrimérica microbicida
JP5322918B2 (ja) * 2006-03-22 2013-10-23 スターファーマ・プロプライエタリー・リミテッド 避妊用組成物

Also Published As

Publication number Publication date
US20120295839A1 (en) 2012-11-22
BR112013029661B1 (pt) 2021-10-13
IL229439A0 (en) 2014-01-30
SMT201900610T1 (it) 2020-01-14
RU2013155620A (ru) 2015-06-27
JP2014515032A (ja) 2014-06-26
JP2016193945A (ja) 2016-11-17
HK1247572A1 (zh) 2018-09-28
PT2709633T (pt) 2019-11-18
CA2836168A1 (en) 2012-11-22
AU2011368322A1 (en) 2013-05-02
CN103687601B (zh) 2017-12-08
HUE047170T2 (hu) 2020-04-28
BR112013029661A2 (pt) 2020-10-06
EP2709633B1 (en) 2019-09-04
KR20180126621A (ko) 2018-11-27
JP6057987B2 (ja) 2017-01-11
EP2709633A1 (en) 2014-03-26
MX2013013473A (es) 2014-06-05
RS59598B1 (sr) 2020-01-31
KR20140040750A (ko) 2014-04-03
WO2012155172A1 (en) 2012-11-22
IL229439A (en) 2017-09-28
CA2836168C (en) 2019-09-24
CY1122258T1 (el) 2020-11-25
HRP20191888T1 (hr) 2020-01-24
MX361009B (es) 2018-11-15
RU2632110C2 (ru) 2017-10-02
PL2709633T3 (pl) 2020-03-31
CN103687601A (zh) 2014-03-26
DK2709633T3 (da) 2019-11-11
AU2011368322B2 (en) 2016-07-21
KR102096114B1 (ko) 2020-04-02
EP2709633A4 (en) 2014-10-15
US9155760B2 (en) 2015-10-13
LT2709633T (lt) 2019-11-25
ES2753531T3 (es) 2020-04-13
CN107669698A (zh) 2018-02-09

Similar Documents

Publication Publication Date Title
GB201110095D0 (en) Method of treatment
EP2773754A4 (en) Methods of Treatment
EP2717855A4 (en) PROCESSING METHODS
PL2696890T3 (pl) Leczenie infekcji drobnoustrojowych
EP2771030A4 (en) COMPOSITIONS AND METHOD FOR THE TREATMENT OF PROTEINOPATHIES
PT3581199T (pt) Métodos de tratamento ou redução de paniculopatia edematosa fibroesclerótica
GB201018147D0 (en) Method of treatment
IL229439A0 (en) A method for treating or preventing bacterial vaginosis
GB201003920D0 (en) Method of treatment
EP2668260A4 (en) METHOD FOR MODIFYING BACTERIA
ZA201308194B (en) Treatment of mastitis
EP2585103A4 (en) METHOD OF TREATMENT
GB201018149D0 (en) Method of treatment
EP2791324A4 (en) PROCESSING METHOD
EP2685820A4 (en) COMPOSITIONS AND METHODS FOR TREATING INFECTIONS
GB201020015D0 (en) Method of treatment
EP2670407A4 (en) TREATMENT OF BACTERIAL INFECTIONS
AU2011902499A0 (en) Method of treatment and prophylaxis
GB201111530D0 (en) Method of treatment
GB201109509D0 (en) Method of treatment
GB201109266D0 (en) Method of treatment
GB201103044D0 (en) Method of treatment
GB201110602D0 (en) Methods of treatment
GB201109737D0 (en) Methods of treatment
AU2011905392A0 (en) Method of treatment